Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D03XJE
|
||||
| Former ID |
DNC005086
|
||||
| Drug Name |
2-Adamantan-2-ylidenemethyl-benzooxazol-6-ol
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [527199] | ||
| Formula |
C18H19NO2
|
||||
| Canonical SMILES |
C1C2CC3CC1CC(C2)C3=CC4=NC5=C(O4)C=C(C=C5)O
|
||||
| InChI |
1S/C18H19NO2/c20-14-1-2-16-17(8-14)21-18(19-16)9-15-12-4-10-3-11(6-12)7-13(15)5-10/h1-2,8-13,20H,3-7H2
|
||||
| InChIKey |
CEAARYLECHJRSD-UHFFFAOYSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Steryl-sulfatase | Target Info | Inhibitor | [527199] | |
| KEGG Pathway | Steroid hormone biosynthesis | ||||
| PathWhiz Pathway | Androgen and Estrogen Metabolism | ||||
| Reactome | Glycosphingolipid metabolism | ||||
| References | |||||